Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety reassessment of ulinastatin for injection
ChiCTR-OPC-15006751Phase 4Recruiting
- Sponsor
- Guangdong Center for Adverse Drug Reaction Monitoring
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulinastatin (2 arms), sponsored by Guangdong Center for Adverse Drug Reaction Monitoring. Primary endpoint: Adverse events and adverse drug reactions. Started Aug 2014; status: recruiting.
02
Drugs
ulinastatin
Beyond the preview
Go deeper on ChiCTR-OPC-15006751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006751.